Neural Omega
HealthOverviewOur approach to healthMaia CorpusFor patientsMaia ClinicalFor specialists
ResearchOverviewOur approach to researchMAR PlatformFor researchersMassa SuiteFor pharma
CompanyAboutTeam and missionMimicryThe scienceEthicsHow we workObservatoryResearch and updates
Language
Contact

Purpose

Ethics by design.

Grounded in
Bioethics and corporate responsibility
Applies to
Science, data, AI and the company
Led by
Chief Purpose Officer

How we think about the meeting point of science, artificial intelligence, the people whose health is at stake and the company we choose to be.

Behind every record is a person who chose to trust us with something intimate.

Whether it can be done, and whether it should.

Bioethics took shape in medicine and research in the second half of the twentieth century, out of a hard lesson: technical progress, on its own, says little about how people are treated. Its four principles anchor our work with patients, data and research.1

Autonomy
Each person decides about their own body, their care and their data.
Beneficence
Every action seeks the good of the person it affects.
Non‑maleficence
Every action is weighed against the harm it could cause.
Justice
Benefits, risks and access are distributed fairly.

Neural Omega works with the same material as a hospital: the health of real people. We build digital infrastructure on their data, and computational models to study it. Each of those steps holds an ethical decision, and so does every choice about how we are funded, who we partner with and what we say in public. We make each one deliberately.

Four fields, one responsibility.

Science, artificial intelligence, clinical data and the company itself meet in our work. Each brings its own duty.

01

Science

From research we inherit the duty to claim exactly what the evidence supports. A strong hypothesis and a conclusion are different things, and keeping them apart matters to anyone looking for hope.

02

Artificial intelligence

A model presents its results with a fluency that can read as certainty, and inherits the biases of its data. Its performance must be examined in every population it serves, starting with the least served.

03

Clinical data

What a person shares about their illness is intimate and reaches us through trust. We treat it as a loan, held for the purpose it was given for and under the control of the person who shared it.2

04

The company

How a company is funded, governed and run shapes what it can promise. We choose investors, partners and incentives aligned with the interests of the people we serve, and we hold ourselves to the same standard inside the company as outside it.

Principles prove themselves in the hard decisions.

The ones that cost time, money or attention. These already guide how we work.

  1. 01

    We say what we can defend

    One register for everyone: what we would stand behind before a scientific reviewer is what we say to an investor. Every public claim matches its real level of validation, and credibility grows from claims that hold over time.

  2. 02

    Judgement stays with people

    Our models propose; experimental evidence and professional judgement decide. Technology is there to strengthen the relationship between patient and clinician, and when a feature invites more trust than the evidence supports, we limit it or remove it, however attractive it may be.

  3. 03

    Data is held in trust

    Personal clinical data is used only for the purpose it was given for, and the person keeps real control over it: to see it, take it with them and withdraw it. Data protection is the legal form of an earlier duty, loyalty to whoever trusted us.2

  4. 04

    We design for everyone affected

    Nearly four in five people with autoimmune disease are women, and innovation tends to reach the best-served first. We build with representativeness and access in mind from the first decision, and we measure our research by whether it becomes accessible solutions.3

The commitment

A commitmentrenewed every day.

These tensions are resolved every day, in concrete decisions, and remain open to scrutiny. The commitment binds the team, the leadership, the founders and those who invest in the project alike.

What we promise is demanding: to keep these questions present in every decision, to accept being held to our own words, and to correct course whenever evidence, experience or error shows us we should.

Behind every principle,
a team.

Ethics is sustained by the people who make decisions every day. Meet who builds Neural Omega, and why.

  1. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 8th ed. New York: Oxford University Press; 2019.
  2. Neural Omega processes personal health data in accordance with Regulation (EU) 2016/679 (General Data Protection Regulation), within the European Union.
  3. Estimate for the United States: 78.8% of people with autoimmune disease are women. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis. 2004;10(11):2005–2011. doi:10.3201/eid1011.040367